Literatures

Primary Site >> Colorectal Cancer

Gene >> TOP1

1.
Journal:	Biochemistry. 1995 May 30;34(21):7200-6.
Title:	Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives.
Author:	Tanizawa, A\|Kohn, K W\|Kohlhagen, G\|Leteurtre, F\|Pommier, Y
PMID:	7766631

2.
Journal:	Cancer Res. 1995 May 15;55(10):2116-21.
Title:	Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Cancer Institute anticancer screen.
Author:	Goldwasser, F\|Bae, I\|Valenti, M\|Torres, K\|Pommier, Y
PMID:	7743511

3.
Journal:	Cancer Res. 1996 Oct 1;56(19):4430-7.
Title:	Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells.
Author:	Goldwasser, F\|Shimizu, T\|Jackman, J\|Hoki, Y\|O'Connor, P M\|Kohn, K W\|Pommier, Y
PMID:	8813137

4.
Journal:	Int J Cancer. 1997 Jan 27;70(3):335-40.
Title:	CPT-11 in human colon-cancer cell lines and xenografts: characterization of cellular sensitivity determinants.
Author:	Jansen, W J\|Zwart, B\|Hulscher, S T\|Giaccone, G\|Pinedo, H M\|Boven, E
PMID:	9033637

5.
Journal:	Mol Pharmacol. 1997 Jul;52(1):82-7.
Title:	Novel 7-alkyl methylenedioxy-camptothecin derivatives exhibit increased cytotoxicity and induce persistent cleavable complexes both with purified mammalian topoisomerase I and in human colon carcinoma SW620 cells.
Author:	Valenti, M\|Nieves-Neira, W\|Kohlhagen, G\|Kohn, K W\|Wall, M E\|Wani, M C\|Pommier, Y
PMID:	9224816

6.
Journal:	Nucleic Acids Res. 1997 Oct 15;25(20):4111-6.
Title:	In vivo sequencing of camptothecin-induced topoisomerase I cleavage sites in human colon carcinoma cells.
Author:	Pondarre, C\|Strumberg, D\|Fujimori, A\|Torres-Leon, R\|Pommier, Y
PMID:	9321666

7.
Journal:	Clin Cancer Res. 1997 Sep;3(9):1653-60.
Title:	Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells.
Author:	Gupta, M\|Fan, S\|Zhan, Q\|Kohn, K W\|O'Connor, P M\|Pommier, Y
PMID:	9815856

8.
Journal:	Oncol Res. 1998;10(5):271-6.
Title:	Replication-dependent and -independent camptothecin cytotoxicity of seven human colon tumor cell lines.
Author:	Borovitskaya, A E\|D'Arpa, P
PMID:	9802062

9.
Journal:	Jpn J Cancer Res. 2000 May;91(5):551-9.
Title:	Identification and characterization of a deletion mutant of DNA topoisomerase I mRNA in a camptothecin-resistant subline of human colon carcinoma.
Author:	Yanase, K\|Sugimoto, Y\|Tsukahara, S\|Oh-Hara, T\|Andoh, T\|Tsuruo, T
PMID:	10835501

10.
Journal:	Clin Cancer Res. 2001 Jan;7(1):185-91.
Title:	Ecteinascidin 743 induces protein-linked DNA breaks in human colon carcinoma HCT116 cells and is cytotoxic independently of topoisomerase I expression.
Author:	Takebayashi, Y\|Goldwasser, F\|Urasaki, Y\|Kohlhagen, G\|Pommier, Y
PMID:	11205907

11.
Journal:	J Clin Oncol. 2001 Mar 1;19(5):1501-18.
Title:	Irinotecan in the treatment of colorectal cancer: clinical overview.
Author:	Vanhoefer, U\|Harstrick, A\|Achterrath, W\|Cao, S\|Seeber, S\|Rustum, Y M
PMID:	11230497

12.
Journal:	Cancer Res. 2001 Aug 1;61(15):5926-32.
Title:	Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells.
Author:	Desai, S D\|Li, T K\|Rodriguez-Bauman, A\|Rubin, E H\|Liu, L F
PMID:	11479235

13.
Journal:	J Biol Chem. 2002 May 10;277(19):17154-60.
Title:	Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin.
Author:	Han, Zhiyong\|Wei, Wenyi\|Dunaway, Stephen\|Darnowski, James W\|Calabresi, Paul\|Sedivy, John\|Hendrickson, Eric A\|Balan, Kannan V\|Pantazis, Panayotis\|Wyche, James H
PMID:	11877436

14.
Journal:	Cancer Res. 2003 Dec 1;63(23):8400-7.
Title:	Characterization of ARC-111 as a novel topoisomerase I-targeting anticancer drug.
Author:	Li, Tsai-Kun\|Houghton, Peter J\|Desai, Shyamal D\|Daroui, Parima\|Liu, Angela A\|Hars, Eszter S\|Ruchelman, Alexander L\|LaVoie, Edmond J\|Liu, Leroy F
PMID:	14679002

15.
Journal:	Br J Cancer. 2005 Jan 31;92(2):259-64.
Title:	Unfavourable expression of pharmacologic markers in mucinous colorectal cancer.
Author:	Glasgow, S C\|Yu, J\|Carvalho, L P\|Shannon, W D\|Fleshman, J W\|McLeod, H L
PMID:	15655543

16.
Journal:	FEBS J. 2005 Feb;272(3):696-710.
Title:	Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells.
Author:	Penuelas, Silvia\|Noe, Veronique\|Ciudad, Carlos J
PMID:	15670151

17.
Journal:	World J Gastroenterol. 2005 Sep 7;11(33):5156-61.
Title:	Amygdalin inhibits genes related to cell cycle in SNU-C4 human colon cancer cells.
Author:	Park, Hae-Jeong\|Yoon, Seo-Hyun\|Han, Long-Shan\|Zheng, Long-Tai\|Jung, Kyung-Hee\|Uhm, Yoon-Kyung\|Lee, Je-Hyun\|Jeong, Ji-Seon\|Joo, Woo-Sang\|Yim, Sung-Vin\|Chung, Joo-Ho\|Hong, Seon-Pyo
PMID:	16127745

18.
Journal:	Br J Cancer. 2006 Oct 9;95(7):906-13.
Title:	Identification of gene polymorphisms of human DNA topoisomerase I in the National Cancer Institute panel of human tumour cell lines.
Author:	Moisan, F\|Longy, M\|Robert, J\|Le Morvan, V
PMID:	16983402

19.
Journal:	J Mol Med (Berl). 2007 Mar;85(3):293-304. Epub 2006 Dec 2.
Title:	Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
Author:	Lassmann, Silke\|Weis, Roland\|Makowiec, Frank\|Roth, Jasmine\|Danciu, Mihai\|Hopt, Ulrich\|Werner, Martin
PMID:	17143621

20.
Journal:	Cancer Res. 2007 Oct 15;67(20):9971-9.
Title:	Batracylin (NSC 320846), a dual inhibitor of DNA topoisomerases I and II induces histone gamma-H2AX as a biomarker of DNA damage.
Author:	Rao, V Ashutosh\|Agama, Keli\|Holbeck, Susan\|Pommier, Yves
PMID:	17942930

21.
Journal:	Clin Cancer Res. 2008 Mar 15;14(6):1788-96.
Title:	Irinotecan pharmacogenetics: influence of pharmacodynamic genes.
Author:	Hoskins, Janelle M\|Marcuello, Eugenio\|Altes, Albert\|Marsh, Sharon\|Maxwell, Taylor\|Van Booven, Derek J\|Pare, Laia\|Culverhouse, Robert\|McLeod, Howard L\|Baiget, Montserrat
PMID:	18347181

22.
Journal:	Mol Cancer Ther. 2009 Jul;8(7):1964-73.
Title:	Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines.
Author:	Crea, Francesco\|Giovannetti, Elisa\|Cortesi, Filippo\|Mey, Valentina\|Nannizzi, Sara\|Gallegos Ruiz, Marielle I\|Ricciardi, Simona\|Del Tacca, Mario\|Peters, Godefridus J\|Danesi, Romano
PMID:	19531575

23.
Journal:	Mol Cancer Ther. 2009 Jul;8(7):1878-84.
Title:	Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity.
Author:	Pfister, Thomas D\|Reinhold, William C\|Agama, Keli\|Gupta, Shalu\|Khin, Sonny A\|Kinders, Robert J\|Parchment, Ralph E\|Tomaszewski, Joseph E\|Doroshow, James H\|Pommier, Yves
PMID:	19584232

24.
Journal:	Orv Hetil. 2009 Aug 23;150(34):1607-13.
Title:	[Tissue microarray (TMA) validated progression markers in colorectal cancer using antibody microarrays].
Author:	Spisak, Sandor\|Galamb, Barnabas\|Wichmann, Barnabas\|Sipos, Ferenc\|Galamb, Orsolya\|Solymosi, Norbert\|Nemes, Balazs\|Tulassay, Zsolt\|Molnar, Bela
PMID:	19648079

25.
Journal:	Cancer Res. 2010 Oct 15;70(20):8055-65.
Title:	Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors.
Author:	Solier, Stephanie\|Barb, Jennifer\|Zeeberg, Barry R\|Varma, Sudhir\|Ryan, Mike C\|Kohn, Kurt W\|Weinstein, John N\|Munson, Peter J\|Pommier, Yves
PMID:	20817775

26.
Journal:	Dis Markers. 2010;28(1):1-14.
Title:	Applicability of antibody and mRNA expression microarrays for identifying diagnostic and progression markers of early and late stage colorectal cancer.
Author:	Spisak, Sandor\|Galamb, Barnabas\|Sipos, Ferenc\|Galamb, Orsolya\|Wichmann, Barnabas\|Solymosi, Norbert\|Nemes, Balazs\|Molnar, Jeannette\|Tulassay, Zsolt\|Molnar, Bela
PMID:	20164542

27.
Journal:	Clin Cancer Res. 2011 May 1;17(9):2777-87.
Title:	Genz-644282, a novel non-camptothecin topoisomerase I inhibitor for cancer treatment.
Author:	Kurtzberg, Leslie S\|Roth, Stephanie\|Krumbholz, Roy\|Crawford, Jennifer\|Bormann, Christy\|Dunham, Sarah\|Yao, Min\|Rouleau, Cecile\|Bagley, Rebecca G\|Yu, Xian-Jie\|Wang, Fei\|Schmid, Steven M\|Lavoie, Edmond J\|Teicher, Beverly A
PMID:	21415217

28.
Journal:	Mol Cancer. 2011 May 27;10:64.
Title:	New Topoisomerase I mutations are associated with resistance to camptothecin.
Author:	Gongora, Celine\|Vezzio-Vie, Nadia\|Tuduri, Sandie\|Denis, Vincent\|Causse, Annick\|Auzanneau, Celine\|Collod-Beroud, Gwenaelle\|Coquelle, Arnaud\|Pasero, Philippe\|Pourquier, Philippe\|Martineau, Pierre\|Del Rio, Maguy
PMID:	21619602

29.
Journal:	Mol Cancer Ther. 2011 Aug;10(8):1490-9.
Title:	Molecular and cellular pharmacology of the novel noncamptothecin topoisomerase I inhibitor Genz-644282.
Author:	Sooryakumar, Dhriti\|Dexheimer, Thomas S\|Teicher, Beverly A\|Pommier, Yves
PMID:	21636699

30.
Journal:	Curr Cancer Drug Targets. 2011 Oct;11(8):976-86.
Title:	RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitors.
Author:	Martin, S E\|Wu, Z-H\|Gehlhaus, K\|Jones, T L\|Zhang, Y-W\|Guha, R\|Miyamoto, S\|Pommier, Y\|Caplen, N J
PMID:	21834757

31.
Journal:	Cancer Res. 2012 Feb 15;72(4):979-89.
Title:	Potentiation of the novel topoisomerase I inhibitor indenoisoquinoline LMP-400 by the cell checkpoint and Chk1-Chk2 inhibitor AZD7762.
Author:	Aris, Sheena M\|Pommier, Yves
PMID:	22189968

32.
Journal:	Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):15030-5.
Title:	Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents.
Author:	Zoppoli, Gabriele\|Regairaz, Marie\|Leo, Elisabetta\|Reinhold, William C\|Varma, Sudhir\|Ballestrero, Alberto\|Doroshow, James H\|Pommier, Yves
PMID:	22927417

33.
Journal:	Mol Oncol. 2013 Feb;7(1):101-11.
Title:	Topoisomerase 1(TOP1) gene copy number in stage III colorectal cancer patients and its relation to prognosis.
Author:	Romer, Maria Unni\|Nygard, Sune Boris\|Christensen, Ib Jarle\|Nielsen, Signe Lykke\|Nielsen, Kirsten Vang\|Muller, Sven\|Smith, David Hersi\|Vainer, Ben\|Nielsen, Hans Jorgen\|Brunner, Nils
PMID:	23110915

34.
Journal:	PLoS One. 2013;8(4):e60613.
Title:	Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort.
Author:	Smith, David Hersi\|Christensen, Ib Jarle\|Jensen, Niels Frank\|Markussen, Bo\|Romer, Maria Unni\|Nygard, Sune Boris\|Muller, Sven\|Nielsen, Hans Jorgen\|Brunner, Nils\|Nielsen, Kirsten Vang
PMID:	23577133

35.
Journal:	Int J Oncol. 2013 Jul;43(1):210-8.
Title:	Influence of MLH1 on colon cancer sensitivity to poly(ADP-ribose) polymerase inhibitor combined with irinotecan.
Author:	Tentori, Lucio\|Leonetti, Carlo\|Muzi, Alessia\|Dorio, Annalisa Susanna\|Porru, Manuela\|Dolci, Susanna\|Campolo, Federica\|Vernole, Patrizia\|Lacal, Pedro Miguel\|Praz, Francoise\|Graziani, Grazia
PMID:	23653048

36.
Journal:	Oncol Rep. 2013 Sep;30(3):1053-8.
Title:	Three missense mutations of DNA topoisomerase I in highly camptothecin-resistant colon cancer cell sublines.
Author:	Arakawa, Yasuhiro\|Ozaki, Koji\|Okawa, Yutaka\|Yamada, Hisashi
PMID:	23836376

37.
Journal:	Curr Top Med Chem. 2014;14(23):2722-8.
Title:	Synthesis and biological evaluation of 1,5-naphthyridines as topoisomerase I inhibitors. A new family of antiproliferative agents.
Author:	Alonso, Concepcion\|Fuertes, Maria\|Gonzalez, Maria\|Rodriguez-Gascon, Alicia\|Rubiales, Gloria\|Palacios, Francisco
PMID:	25515747

38.
Journal:	J Med Chem. 2014 Feb 27;57(4):1289-98.
Title:	Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.
Author:	Kiselev, Evgeny\|Sooryakumar, Dhriti\|Agama, Keli\|Cushman, Mark\|Pommier, Yves
PMID:	24502276

39.
Journal:	Mol Oncol. 2015 Jun;9(6):1207-17.
Title:	Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers.
Author:	Sonderstrup, Ida Marie Heeholm\|Nygard, Sune Boris\|Poulsen, Tim Svenstrup\|Linnemann, Dorte\|Stenvang, Jan\|Nielsen, Hans Jorgen\|Bartek, Jiri\|Brunner, Nils\|Norgaard, Peter\|Riis, Lene
PMID:	25777966

40.
Journal:	Database (Oxford). 2015 Mar 27;2015. pii: bav015.
Title:	Colorectal cancer drug target prediction using ontology-based inference and network analysis.
Author:	Tao, Cui\|Sun, Jingchun\|Zheng, W Jim\|Chen, Junjie\|Xu, Hua
PMID:	25818893

41.
Journal:	BMC Cancer. 2015 Feb 21;15:78.
Title:	A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocol.
Author:	Kumler, Iben\|Balslev, Eva\|Stenvang, Jan\|Brunner, Nils\|Nielsen, Dorte
PMID:	25885574

42.
Journal:	Clin Cancer Res. 2016 Apr 1;22(7):1621-31.
Title:	DNA Topoisomerase I Gene Copy Number and mRNA Expression Assessed as Predictive Biomarkers for Adjuvant Irinotecan in Stage II/III Colon Cancer.
Author:	Nygard, Sune Boris\|Vainer, Ben\|Nielsen, Signe Lykke\|Bosman, Fred\|Tejpar, Sabine\|Roth, Arnaud\|Delorenzi, Mauro\|Brunner, Nils\|Budinska, Eva
PMID:	26542057

43.
Journal:	Int J Mol Med. 2016 Feb;37(2):319-28.
Title:	Association between mRNA expression of chemotherapy-related genes and clinicopathological features in colorectal cancer: A large-scale population analysis.
Author:	Shimamoto, Yuji\|Nukatsuka, Mamoru\|Takechi, Teiji\|Fukushima, Masakazu
PMID:	26676887

44.
Journal:	PLoS One. 2016 Jan 19;11(1):e0147053.
Title:	Dynamic Effects of Topoisomerase I Inhibition on R-Loops and Short Transcripts at Active Promoters.
Author:	Marinello, Jessica\|Bertoncini, Stefania\|Aloisi, Iris\|Cristini, Agnese\|Malagoli Tagliazucchi, Guidantonio\|Forcato, Mattia\|Sordet, Olivier\|Capranico, Giovanni
PMID:	26784695

45.
Journal:	J Exp Clin Cancer Res. 2016 Mar 31;35:56.
Title:	Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.
Author:	Jensen, Niels Frank\|Agama, Keli\|Roy, Amit\|Smith, David Hersi\|Pfister, Thomas D\|Romer, Maria Unni\|Zhang, Hong-Liang\|Doroshow, James H\|Knudsen, Birgitta R\|Stenvang, Jan\|Brunner, Nils\|Pommier, Yves
PMID:	27029323

46.
Journal:	Br J Cancer. 2016 Dec 6;115(12):1555-1564.
Title:	A protein fragment derived from DNA-topoisomerase I as a novel tumour-associated antigen for the detection of early stage carcinoma.
Author:	Yie, Shang-Mian\|Ye, Shang-Rong\|Ma, Xiao-Li\|Xie, Ke\|Zhang, Jian-Bo\|Cao, Mei\|He, Xu\|Hu, Zhen-Bo\|Yang, Cheng-Lu\|Zhang, Jia\|Zeng, Jie
PMID:	27875523

47.
Journal:	Nucleic Acids Res. 2017 Feb 17;45(3):1159-1176.
Title:	Epigenetic changes in histone acetylation underpin resistance to the topoisomerase I inhibitor irinotecan.
Author:	Meisenberg, Cornelia\|Ashour, Mohamed E\|El-Shafie, Lamia\|Liao, Chunyan\|Hodgson, Adam\|Pilborough, Alice\|Khurram, Syed A\|Downs, Jessica A\|Ward, Simon E\|El-Khamisy, Sherif F
PMID:	28180300

48.
Journal:	Biochem Pharmacol. 2017 Dec 15;146:53-62.
Title:	Camptothecin and its analog SN-38, the active metabolite of irinotecan, inhibit binding of the transcriptional regulator and oncoprotein FUBP1 to its DNA target sequence FUSE.
Author:	Khageh Hosseini, Sabrina\|Kolterer, Stefanie\|Steiner, Marlene\|von Manstein, Viktoria\|Gerlach, Katharina\|Trojan, Jorg\|Waidmann, Oliver\|Zeuzem, Stefan\|Schulze, Jorg O\|Hahn, Steffen\|Steinhilber, Dieter\|Gatterdam, Volker\|Tampe, Robert\|Biondi, Ricardo M\|Proscha
PMID:	29031818

49.
Journal:	Mol Cancer Ther. 2018 Aug;17(8):1694-1704.
Title:	Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors.
Author:	Marzi, Laetitia\|Agama, Keli\|Murai, Junko\|Difilippantonio, Simone\|James, Amy\|Peer, Cody J\|Figg, William D\|Beck, Daniel\|Elsayed, Mohamed S A\|Cushman, Mark\|Pommier, Yves
PMID:	29748210

50.
Journal:	Oncol Lett. 2018 Oct;16(4):4640-4648.
Title:	Total ginsenosides of Chinese ginseng induces cell cycle arrest and apoptosis in colorectal carcinoma HT-29 cells.
Author:	Li, Ting\|Sun, Wan\|Dong, Xiaoqiao\|Yu, Wenhua\|Cai, Jianyong\|Yuan, Qiang\|Shan, Letian\|Efferth, Thomas
PMID:	30197678